GlassScriptPhysician profile
Joel David Siegal
NPI 1548243009
$111,616.53
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,955 · 2020: $295 · 2021: $7,740 · 2022: $40K · 2023: $11K · 2024: $25K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Travel and Lodging: $6,473 · Food and Beverage: $1,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,851.96 |
| Travel and Lodging | $6,473.49 |
| Food and Beverage | $1,546.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $66,583.49 | 2021-2025 | Firebird, Firebird Sfs, Firebird Si |
| Medacta USA, INC. | $24,518.98 | 2019-2025 | Myspine, Myknee, Must |
| Si-Bone, INC. | $13,554.16 | 2019-2022 | |
| Trice Medical, INC. | $1,579.28 | 2021 | |
| Captiva Spine INC | $1,356.88 | 2019 | |
| Aesculap Implant Systems, LLC | $1,191.41 | 2021-2023 | Activl |
| Globus Medical, INC. | $1,075.54 | 2019 | |
| Stimwave Technologies Incorporated | $741.02 | 2019 | |
| Intrinsic Therapeutics | $349.50 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Centinel Spine, LLC | $203.66 | 2025 | Prodisc C, Prodisc L |
| Innovasis INC | $148.77 | 2021 | |
| Nevro Corp. | $104.32 | 2020 | |
| Depuy Synthes Sales INC. | $62.99 | 2019 | |
| Jazz Pharmaceuticals INC. | $36.44 | 2023 | |
| Ethicon US, LLC | $27.41 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $20.43 | 2024 | |
| Merck Sharp & Dohme LLC | $16.67 | 2023 | Bridion |
| Bayer Healthcare Pharmaceuticals INC. | $16.04 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.04 | 2025 | Caplyta |
| Aimmune Therapeutics, INC. | $13.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Siegal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.